SI-BONE Inc logo

SIBN

SI-BONE Inc

$17.72

Earnings Summary

Revenue
$22.44Mn
Net Profits
$-17.41Mn
Net Profit Margins
-77.59%

Highlights

Revenue:

SI-BONE Inc’s revenue jumped 9.77% since last year same period to $22.44Mn in the Q1 2022. On a quarterly growth basis, SI-BONE Inc has generated -11.06% fall in its revenue since last 3-months.

Net Profits:

SI-BONE Inc’s net profit fell -42.22% since last year same period to $-17.41Mn in the Q1 2022. On a quarterly growth basis, SI-BONE Inc has generated -20.26% fall in its net profits since last 3-months.

Net Profit Margins:

SI-BONE Inc’s net profit margin fell -29.56% since last year same period to -77.59% in the Q1 2022. On a quarterly growth basis, SI-BONE Inc has generated -35.22% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the SI-BONE Inc post its latest quarter earnings

EPS Estimate Current Quarter
-0.49
EPS Estimate Current Year
-0.49

Highlights

EPS Estimate Current Quarter:

SI-BONE Inc’s earning per share (EPS) estimates for the current quarter stand at -0.49 - a -13.95% fall from last quarter’s estimates.

EPS Estimate Current Year:

SI-BONE Inc’s earning per share (EPS) estimates for the current year stand at -0.49.

Key Ratios

Key ratios of the SI-BONE Inc post its Q1 2022 earnings

Earning Per Share (EPS)
-0.52
Return on Assets (ROA)
-0.21
Return on Equity (ROE)
-0.5
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

SI-BONE Inc’s earning per share (EPS) fell -40.54% since last year same period to -0.52 in the Q1 2022. This indicates that the SI-BONE Inc has generated -40.54% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. SI-BONE Inc’s return on assets (ROA) stands at -0.21.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. SI-BONE Inc’s return on equity (ROE) stands at -0.5.

Dividend Per Share (DPS):

SI-BONE Inc declared 0 dividend per share during the earnings announcement for Q1 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-05-10
-0.43
-0.52
-20.93%

Company Information

SI-BONE is a medical device company that pioneered minimally invasive surgery of the SI joint with the iFuse Implant System. Studies have shown that the SI joint can be a source of pain in 15% to 30% of chronic low back pain. The iFuse Implant™, commercially available since 2009, is the only SI joint fusion device supported by multiple prospective clinical studies, including two randomized controlled trials, showing improved pain, patient function and quality of life resulting from treatment. There are over 90 peer-reviewed publications demonstrating the safety, durable effectiveness, and biomechanical and economic benefits unique to the iFuse Implant (www.si-bone.com/results). This body of evidence has enabled multiple government and private insurance payors to establish coverage of the SI joint fusion procedure exclusively when performed with the iFuse Implant System.

Organisation
SI-BONE Inc
Headquarters
Santa Clara, California, US
Employees
295
Industry
Health Technology
CEO
Jeffrey Dunn